Gaingels GC Therapeutics LLC
Gaingels Ventures · adviser of record: Gaingels Ventures LLC · 2023 vintage
Gaingels GC Therapeutics LLC is a 2023 venture fund managed by Gaingels Ventures, with $340k raised (Form D, amount sold). It reported $3.1mm in gross assets at year-end 2024, 9.15x its size, against a peak of $3.1mm in 2023.
- Latest value held
- $3.1mm year-end 2024
- Peak
- $3.1mm year-end 2023
- Fund size
- $340k Form D, amount sold
- Held vs. size
- 9.15x peak 9.15x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2024 archived filing | $3.1mm | 9.15x | +0% |
| 2023 | $3.1mm | 9.15x | – |
Other funds from Gaingels Ventures
- Gaingels AI Fund I LLC 2023
- Gaingels Fintech I LLC 2023
- Gaingels Healthcare I LLC 2023
- Gaingels Holdings Core 2023 LLC 2023
- Gaingels Rain Neuromorphics 2023 LLC 2023
- Gaingels Petal LLC 2023
- Gaingels Spark IV LLC 2023
- Gaingels Abingdon LLC 2023
- Gaingels Fathom Radiant LLC 2023
- Gaingels Shield AI 2023 LLC 2023
- Gaingels TFH LLC 2022
- Gaingels Spark III LLC 2022
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-5963462971. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.